Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

External agents penetrate skin more easily in areas with fewer lipids, especially through hair follicles.

PCOS is linked to low-grade chronic inflammation.

Current methods for grading hair loss from cancer treatment are not accurate enough and need improvement.

New method accurately measures finasteride in tablets and bulk.

The BHBS is a valid tool to study cultural norms and breast cancer risk in Black women.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

Spironolactone is used in dermatology to treat skin conditions related to hormones, but is not safe for pregnant women or men.

Trichoscopic measurements help determine the severity of female pattern hair loss.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Porcine ADM scaffold helps hair growth in mice.

The composite sponge helps heal diabetic wounds by reducing inflammation and promoting new blood vessel growth.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Widened sweat ducts are a very specific sign of scarring hair loss.

Laser ablation ICP-MS is effective for tracking trace elements in polar bear hair over time.

Botulinum toxin use in dermatology is evolving, with new research trends emerging.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Single-spin PRP may be more effective for treating hair loss.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

Higher apelin-12 levels may indicate more severe acne.